Alternatives to QuantHealth

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omnix Medical is developing a novel platform for advanced wound care management.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Cloud-based platform for reproducible computational research in life sciences.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.